subscribeSubscribe
Enforcement Report - Week of November 2, 2022

Enforcement Report - Week of November 2, 2022
FDA
02 Nov 2022
Share Share
Scinopharm Taiwan Generic Fondaparinux Sodium Receives Approval in US

Scinopharm Taiwan Generic Fondaparinux Sodium Receives Approval in US
FDA
16 Nov 2018
Share Share
Jiangsu Hengrui’s Generic Fondaparinux Sodium Receives Approval In US

Jiangsu Hengrui’s Generic Fondaparinux Sodium Receives Approval In US
FDA
18 May 2018
Share Share
AuroMedics’ double take: Glass in vials prompts another recall in US

AuroMedics’ double take: Glass in vials prompts another recall in US
Flora Southey IN PHARMATECHNOLOGIST
05 Jan 2018
Share Share
Aurobindo Pharma’s Generic Fondaparinux Sodium Receives Approval In US

Aurobindo Pharma’s Generic Fondaparinux Sodium Receives Approval In US
FDA
29 Dec 2017
Share Share
Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection

Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection
ECONOMIC TIMES
27 Dec 2017
Share Share
CCI clears Abbott-St Jude deal subject to `voluntary remedies`

CCI clears Abbott-St Jude deal subject to `voluntary remedies`
ECONOMIC TIMES
19 Dec 2016
Share Share
Dr Reddy`s buys IPR for anti-coagulant drug for $17.5 million

Dr Reddy`s buys IPR for anti-coagulant drug for $17.5 million
PTI ECONOMIC TIMES
19 Nov 2015
Share Share
Dr Reddy`s completes purchase of Fondaparinux

Dr Reddy`s completes purchase of Fondaparinux
B Dasarath Reddy BUSINESS STANDARD
18 Nov 2015
Share Share
Dr Reddy`s Laboratories to buy IP rights of fondaparinux for $17.5 million

Dr Reddy`s Laboratories to buy IP rights of fondaparinux for $17.5 million
PTI THE ECONOMIC TIMES
26 Sep 2015
Share Share